A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Ho, Yan Teck ^a   Adriani, Giulia ^b   Beyer, Sebastian ^b,c   Nhan, Phan Thien ^a,d   Kamm, Roger D ^b,e   Kah, James Chen Yong ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c Federal Institute for Materials Research and Testing Germany   (Germany)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; CYCLIC AMP; DEXTRAN; NANOPARTICLE; POLYSTYRENE DERIVATIVE;

ALGORITHM; BIOLOGICAL MODEL; CAPILLARY PERMEABILITY; CELL CULTURE; CHEMISTRY; DIFFUSION; DRUG EFFECT; HUMAN; LAB ON A CHIP; METABOLISM; NANOMEDICINE; PROCEDURES; UMBILICAL VEIN ENDOTHELIAL CELL;

ALGORITHMS; ANGIOTENSIN I; CAPILLARY PERMEABILITY; CELLS, CULTURED; CYCLIC AMP; DEXTRANS; DIFFUSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAB-ON-A-CHIP DEVICES; MODELS, BIOLOGICAL; NANOMEDICINE; NANOPARTICLES; POLYSTYRENES;

EID: 85018436183     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00750-3     Document Type: Article

References (93)

1. De Jong, W. H. & Borm, P. J. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3, 133-149 (2008).
2. Kim, K. Y. Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine 3, 103-110, doi:10.1016/j. nano.2006.12.002 (2007).
3. Kim, Y. D. et al. Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy. Nanomedicine (Lond) 10, 1165-1188, doi:10.2217/nnm.14.214 (2015).
4. He, X. W. et al. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. Cancer Gene Ther 15, 193-202, doi:10.1038/sj.cgt.7701122 (2008).
5. Yang, N. et al. Active targeting docetaxel-PLA nanoparticles eradicate circulating lung cancer stem-like cells and inhibit liver metastasis. Mol Pharm 12, 232-239, doi:10.1021/mp500568z (2015).
6. Shirshahi, V., Shamsipour, F., Zarnani, A. H., Verdi, J. & Saber, R. Active targeting of HER2-positive breast cancer cells by Herceptinfunctionalized organically modified silica nanoparticles. Cancer Nanotechnol 4, 27-37, doi:10.1007/s12645-013-0035-6 (2013).
7. Bazak, R., Houri, M., Achy, S. E., Hussein, W. & Refaat, T. Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Mol Clin Oncol 2, 904-908, doi:10.3892/mco.2014.356 (2014).
8. Chithrani, B. D., Ghazani, A. A. & Chan, W. C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano letters 6, 662-668 (2006).
9. Coester, C., Langer, K., Von Briesen, H. & Kreuter, J. Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptake. Journal of microencapsulation 17, 187-193 (2000).
10. Baldi, A. et al. Biological effects of milk proteins and their peptides with emphasis on those related to the gastrointestinal ecosystem. J Dairy Res 72 Spec No, 66-72 (2005).
11. Adriani, G. et al. The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials 33, 5504-5513, doi:10.1016/j.biomaterials.2012.04.027 (2012).
12. Kong, G., Braun, R. D. & Dewhirst, M. W. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 60, 4440-4445 (2000).
13. Dreher, M. R. et al. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98, 335-344, doi:10.1093/jnci/djj070 (2006).
14. Lampugnani, M. G. & Dejana, E. In Methods in Endothelial Cell Biology 103-113 (Springer, 2004).
15. Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6, 460-463, doi:10.1038/74725 (2000).
16. Pizurki, L., Zhou, Z., Glynos, K., Roussos, C. & Papapetropoulos, A. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 139, 329-336, doi:10.1038/sj.bjp.0705259 (2003).
17. Gamble, J. R. et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87, 603-607 (2000).
18. Beese, M., Wyss, K., Haubitz, M. & Kirsch, T. Effect of cAMP derivates on assembly and maintenance of tight junctions in human umbilical vein endothelial cells. BMC Cell Biol 11, 68, doi:10.1186/1471-2121-11-68 (2010).
19. Casnocha, S. A., Eskin, S. G., Hall, E. R. & McIntire, L. V. Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J Appl Physiol (1985) 67, 1997-2005 (1989).
20. Podduturi, V. P., Magaña, I. B., ONeal, D. P. & Derosa, P. A. Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect. Comput Methods Programs Biomed 112, 58-68, doi:10.1016/j. cmpb.2013.06.011.
21. Goodman, T. T., Chen, J., Matveev, K. & Pun, S. H. Spatio-Temporal modeling of nanoparticle delivery to multicellular tumor spheroids. Biotechnol Bioeng 101, 388-399, doi:10.1002/bit.21910 (2008).
22. Liu, Y., Shah, S. & Tan, J. Computational modeling of nanoparticle targeted drug delivery. Reviews in Nanoscience and Nanotechnology 1, 66-83 (2012).
23. Kiss, A. L. & Botos, E. Endocytosis via caveolae: Alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J Cell Mol Med 13, 1228-1237, doi:10.1111/j.1582-4934.2009.00754.x (2009).
24. Treuel, L., Jiang, X. & Nienhaus, G. U. New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 10, 20120939, doi:10.1098/rsif.2012.0939 (2013).
25. Tuma, P. & Hubbard, A. L. Transcytosis: crossing cellular barriers. Physiological reviews 83, 871-932, doi:10.1152/physrev.00001.2003 (2003).
26. Harush-Frenkel, O., Rozentur, E., Benita, S. & Altschuler, Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9, 435-443, doi:10.1021/bm700535p (2008).
27. Ye, D. et al. Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale 5, 11153-11165, doi:10.1039/c3nr02905k (2013).
28. Price, G. M. & Tien, J. Subtractive methods for forming microfluidic gels of extracellular matrix proteins. Microdevices in biology and engineering. Boston, MA: Artech House, 235-248 (2009).
29. Chrobak, K. M., Potter, D. R. & Tien, J. Formation of perfused, functional microvascular tubes in vitro. Microvascular research 71, 185-196 (2006).
30. Price, G. M., Chrobak, K. M. & Tien, J. Effect of cyclic AMP on barrier function of human lymphatic microvascular tubes. Microvasc Res 76, 46-51, doi:10.1016/j.mvr.2008.02.003 (2008).
31. Price, G. M. & Tien, J. In Biological Microarrays 281-293 (Springer, 2011).
32. Kim, Y. et al. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proceedings of the National Academy of Sciences 111, 1078-1083 (2014).
33. Huxley, V. H., Curry, F. E. & Adamson, R. H. Quantitative fluorescence microscopy on single capillaries: Alpha-lactalbumin transport. The American journal of physiology 252, H188-197 (1987).
34. Yuan, S. Y. & Rigor, R. R. Methods for measuring permeability (2010).
35. Zervantonakis, I. K. et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proceedings of the National Academy of Sciences of the United States of America 109, 13515-13520, doi:10.1073/pnas.1210182109 (2012).
36. Tang, S. K. & Whitesides, G. M. Basic microfluidic and soft lithographic techniques. Optofluidics: Fundamentals, Devices and Applications, Y. Fainman, L. Lee, D. Psaltis, and C. Yang, eds (McGraw-Hill, 2010) (2009).
37. Xia, Y. & Whitesides, G. M. Soft lithography. Annual review of materials science 28, 153-184 (1998).
38. Michel, C. C. & Curry, F. E. Microvascular permeability. Physiol Rev 79, 703-761 (1999).
39. Adamson, R. H., Liu, B., Fry, G. N., Rubin, L. L. & Curry, F. E. Microvascular permeability and number of tight junctions are modulated by cAMP. The American journal of physiology 274, H1885-1894 (1998).
40. Curry, F. R. & Noll, T. Spotlight on microvascular permeability. Cardiovasc Res 87, 195-197, doi:10.1093/cvr/cvq188 (2010).
41. Bischoff, I. et al. Pitfalls in assessing microvascular endothelial barrier function: impedance-based devices versus the classic macromolecular tracer assay. Scientific reports 6 (2016).
42. Aref, A. R. et al. Screening therapeutic EMT blocking agents in a three-dimensional microenvironment. Integr Biol (Camb) 5, 381-389, doi:10.1039/c2ib20209c (2013).
43. Vickerman, V. & Kamm, R. D. Mechanism of a flow-gated angiogenesis switch: early signaling events at cell-matrix and cell-cell junctions. Integr Biol (Camb) 4, 863-874, doi:10.1039/c2ib00184e (2012).
44. Renkin, E. M. In Endothelial Cell Biology in Health and Disease 51-68 (Springer, 1988).
45. Florey, L. The endothelial cell. Br Med J 2, 487-490 (1966).
46. Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro-oncology 7, 452-464, doi:10.1215/S1152851705000232 (2005).
47. Potgens, A. J., Westphal, H. R., de Waal, R. M. & Ruiter, D. J. The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol Chem Hoppe Seyler 376, 57-70 (1995).
48. Dvorak, H. F. Vascular permeability to plasma, plasma proteins, and cells: An update. Curr Opin Hematol 17, 225-229, doi:10.1097/MOH.0b013e3283386638 (2010).
49. Iyer, A. K., Khaled, G., Fang, J. & Maeda, H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11, 812-818, doi:10.1016/j.drudis.2006.07.005 (2006).
50. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41, 189-207 (2001).
51. Stoeltzing, O. et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res 63, 3370-3377 (2003).
52. Komarova, Y. & Malik, A. B. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72, 463-493, doi:10.1146/annurev-physiol-021909-135833 (2010).
53. Papapetropoulos, A. et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275, 9102-9105 (2000).
54. Jones, N., Iljin, K., Dumont, D. J. & Alitalo, K. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2, 257-267, doi:10.1038/35067005 (2001).
55. Gavard, J., Patel, V. & Gutkind, J. S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14, 25-36, doi:10.1016/j.devcel.2007.10.019 (2008).
56. Sperling, R. A. & Parak, W. J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci 368, 1333-1383, doi:10.1098/rsta.2009.0273 (2010).
57. Jho, D. et al. Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2 influx. Circ Res 96, 1282-1290, doi:10.1161/01.RES.0000171894.03801.03 (2005).
58. Hisatsune, C. et al. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J Biol Chem 279, 18887-18894, doi:10.1074/jbc.M311274200 (2004).
59. Vazquez, G., Wedel, B. J., Kawasaki, B. T., Bird, G. S. & Putney, J. W. Jr. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J Biol Chem 279, 40521-40528, doi:10.1074/jbc.M405280200 (2004).
60. Moore, T. M., Chetham, P. M., Kelly, J. J. & Stevens, T. Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. The American journal of physiology 275, L203-222 (1998).
61. Stelzner, T. J., Weil, J. V. & OBrien, R. F. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol 139, 157-166, doi:10.1002/jcp.1041390122 (1989).
62. Smith, P. J. et al. Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. Int J Nanomedicine 7, 2045-2055, doi:10.2147/IJN.S29334 (2012).
63. Podduturi, V. P., Magana, I. B., ONeal, D. P. & Derosa, P. A. Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect. Comput Methods Programs Biomed 112, 58-68, doi:10.1016/j. cmpb.2013.06.011 (2013).
64. Pappenheimer, J. R., Renkin, E. M. & Borrero, L. M. Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability. The American journal of physiology 167, 13-46 (1951).
65. Bentley, K. et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol 16, 309-321, doi:10.1038/ncb2926 (2014).
66. Yeo, E. L. L. et al. Understanding aggregation-based assays: nature of protein corona and number of epitopes on antigen matters. RSC Advances 5, 14982-14993, doi:10.1039/C4RA12089B (2015).
67. Ho, Y. T., Poinard, B., Yeo, E. L. & Kah, J. C. An instantaneous colorimetric protein assay based on spontaneous formation of a protein corona on gold nanoparticles. Analyst 140, 1026-1036, doi:10.1039/c4an01819b (2015).
68. Lundqvist, M. et al. The evolution of the protein corona around nanoparticles: A test study. ACS nano 5, 7503-7509 (2011).
69. Adkins, W. K. et al. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. Journal of Applied Physiology 72, 492-497 (1992).
70. Foy, T., Marion, J., Brigham, K. L. & Harris, T. R. Isoproterenol and aminophylline reduce lung capillary filtration during high permeability. J Appl Physiol Respir Environ Exerc Physiol 46, 146-151 (1979).
71. Lum, H. et al. Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. The American journal of physiology 277, C580-588 (1999).
72. Suttorp, N. et al. Adenosine diphosphate-ribosylation of G-Actin by botulinum C2 toxin increases endothelial permeability in vitro. J Clin Invest 87, 1575-1584, doi:10.1172/JCI115171 (1991).
73. Stevens, T. et al. Ca(2+)-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function. Proceedings of the National Academy of Sciences of the United States of America 92, 2696-2700 (1995).
74. Cullere, X. et al. Regulation of vascular endothelial barrier function by Epac, a cAMP-Activated exchange factor for Rap GTPase. Blood 105, 1950-1955, doi:10.1182/blood-2004-05-1987 (2005).
75. Fukuhara, S. et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25, 136-146, doi:10.1128/MCB.25.1.136-146.2005 (2005).
76. Kooistra, M. R., Corada, M., Dejana, E. & Bos, J. L. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579, 4966-4972, doi:10.1016/j.febslet.2005.07.080 (2005).
77. Qiao, J., Huang, F. & Lum, H. PKA inhibits RhoA activation: A protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284, L972-980, doi:10.1152/ajplung.00429.2002 (2003).
78. Garcia, J. G., Lazar, V., Gilbert-McClain, L. I., Gallagher, P. J. & Verin, A. D. Myosin light chain kinase in endothelium: molecular cloning and regulation. Am J Respir Cell Mol Biol 16, 489-494, doi:10.1165/ajrcmb.16.5.9160829 (1997).
79. Verin, A. D., Gilbert-McClain, L. I., Patterson, C. E. & Garcia, J. G. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol 19, 767-776, doi:10.1165/ajrcmb.19.5.3126 (1998).
80. Vandenbroucke, E., Mehta, D., Minshall, R. & Malik, A. B. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123, 134-145, doi:10.1196/annals.1420.016 (2008).
81. Mehta, D. & Malik, A. B. Signaling mechanisms regulating endothelial permeability. Physiological reviews 86, 279-367, doi:10.1152/physrev.00012.2005 (2006).
82. Ghitescu, L., Fixman, A., Simionescu, M. & Simionescu, N. Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J Cell Biol 102, 1304-1311 (1986).
83. Minshall, R. D. et al. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J Cell Biol 150, 1057-1070 (2000).
84. Predescu, D. & Palade, G. E. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. The American journal of physiology 265, H725-733 (1993).
85. Schnitzer, J. E. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. The American journal of physiology 262, H246-254 (1992).
86. Schnitzer, J. E., Allard, J. & Oh, P. NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia. The American journal of physiology 268, H48-55 (1995).
87. Jain, R. K. & Stylianopoulos, T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7, 653-664, doi:10.1038/nrclinonc.2010.139 (2010).
88. Bertrand, N., Wu, J., Xu, X., Kamaly, N. & Farokhzad, O. C. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66, 2-25, doi:10.1016/j.addr.2013.11.009 (2014).
89. Alexandrakis, G. et al. Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors. Nat Med 10, 203-207, doi:10.1038/nm981 (2004).
90. Jiang, W., Huang, Y., An, Y. & Kim, B. Y. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. ACS Nano 9, 8689-8696, doi:10.1021/acsnano.5b02028 (2015).
91. Elbert, K. J. et al. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharmaceutical research 16, 601-608 (1999).
92. Mahler, G. J. et al. Oral exposure to polystyrene nanoparticles affects iron absorption. Nature nanotechnology 7, 264-271 (2012).
93. Adriani, G., Ma, D., Pavesi, A., Goh, E. & Kamm, R. In 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). 338-341 (IEEE).